Biotech Founder Claims He Was Excluded From GSK Deal
The co-founder of a defunct biotech company said his business partners froze him out of an asthma drug venture that was eventually snapped up by GlaxoSmithKline for $1.4 billion, in a...To view the full article, register now.
Already a subscriber? Click here to view full article